38 results
8-K/A
RVPH
Reviva Pharmaceuticals Holdings Inc.
14 Nov 23
Changes in Registrant's Certifying Accountant
4:15pm
with the Securities and Exchange Commission (“SEC”), that Armanino LLP’s engagement and tenure as the Company’s independent registered public accounting … as described in the October 2023 Form 8-K, on November 14, 2023: (i) Armanino LLP’s engagement and tenure as the Company’s independent registered
8-K
RVPH
Reviva Pharmaceuticals Holdings Inc.
4 Oct 23
Changes in Registrant's Certifying Accountant
5:02pm
of the Company’s unaudited financial statements for the third quarter of 2023, which Armanino remains engaged to complete. Armanino’s engagement and tenure
424B4
9me8ykds
18 Oct 22
Prospectus supplement with pricing info
7:01am
424B4
qvyk1n7xcu8p
28 May 21
Prospectus supplement with pricing info
4:06pm
424B4
vjtffawu xo
17 May 21
Prospectus supplement with pricing info
12:00am
POS AM
xtheh9b
12 May 21
Prospectus update (post-effective amendment)
4:34pm
424B4
ri6z0j
29 Mar 21
Prospectus supplement with pricing info
4:07pm
POS AM
527 j4b068myxkzjij
25 Mar 21
Prospectus update (post-effective amendment)
4:34pm